Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A careers event held by NDORMS offered information and advice to postdoctoral researchers transitioning to becoming independent group leaders.

None
The event included a panel discussion with (from left to right): Prof Fiona Powrie (Director, Kennedy Institute), Dr Sophie Acton (UCL), Dr Chris Toseland (U Sheffield), Prof Mark Coles (Kennedy Institute) and Abigail Reynolds (BBSRC)

NDORMS was delighted to host a Career Education and Networking Event last month aimed at postdoctoral researchers and their transition to becoming independent Principal Investigators (PIs).

The afternoon and evening event included information on suitable funding schemes and application advice by Wellcome, BBSRC and MRC representatives in an open and informal session. This was followed by the highly regarded analysis of postdoc career progression by ‘A survey of new PIs in the UK’ authors Sophie Acton and Chris Toseland, which offered practical, real-world information for new and prospective PIs on relevant topics such as gender issues, research group dynamics, negotiation, salary, start-up costs.

The event was organised by NDORMS Postdoc Advisor Prof James Edwards, together with Drs Emily Thornton and Natasha Whibley representing the Kennedy Postdoc Committee.

Speaking of the event James said, "It was wonderful to see so much active engagement between our NDORMS post doc group and invited speakers, and is clear that such sessions make a strong and worthwhile contribution to the successful career development of NDORMS post docs and to their plans for the future".

“We were thrilled to secure an exciting range of panellists and were grateful for their varied perspectives. The suggestions from Sophie and Chris to those applying for PI positions follows a survey of almost 400 PIs across the UK, and their advice was timely and relevant for many of the postdocs here in NDORMS who are looking towards independent careers”, said Emily.

The NDORMS Postdoc Advisor team would welcome all feedback and suggestions for future events and new ways in which NDORMS postdocs might be supported.

 
   
   

Similar stories

Professor Michael Dustin appointed new Chair in Molecular Immunology

A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.

Empowering data science for single-cell analysis in Zimbabwe

An innovative computational biology training module was launched in November 2022 at the African Institute of Biomedical Science and Technology (AiBST) in Harare, Zimbabwe, where MSc students were trained in single-cell RNA sequencing data analysis.

T-cell coreceptors are well endowed—with kinases!

The kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.